Currently Viewing:
AMCP 2017
Dr Jennifer Graff on How Payers Make Decisions
August 01, 2017
Laura Topor Discusses Challenges of e-Prescribing Specialty Medications
July 11, 2017
Dr Jacqueline Glover: Financial Knowledge Is Part of Informed Consent
July 10, 2017
Laura Topor Explains the Value of Real-Time Benefit Transactions
June 27, 2017
Dr Jacqueline Glover: Clinicians' Obligations of Justice Regarding Costs of Care
June 24, 2017
Dr Lou Garrison Discusses Challenges of Working With Real-World Data
June 16, 2017
Dr Neil Minkoff Explains How 340B Impacts Pharmacies and Payers Differently
June 15, 2017
Dr Matthew Pickering on Working With Health Plans on Measure Implementation
June 09, 2017
Laura Topor: Clearing Up Misconceptions About e-Prescribing
June 07, 2017
Dr Jacqueline Glover Discusses the Complicated Balance of Ethics in Drug Trials
June 05, 2017
Dr Richard J. Willke Discusses Challenges of Working With Real-World Data
June 02, 2017
Susan A. Cantrell Explains the Necessity of Pre- and Post-Approval Communications
May 31, 2017
Dr Neil Minkoff Discusses Evolution and Consequences of 340B Programs
May 30, 2017
Dr Doug Hillblom Discusses Legislative Pushes Toward e-Prescribing
May 25, 2017
Currently Reading
Dr Matthew Pickering Describes Challenges of New Measure Implementation
May 24, 2017
Dr Gail Bridges on the Importance of Real-World Results Matching Clinical Trial Outcomes
May 21, 2017
Dr Liz Zhou Discusses Real-World Implications of Toujeo Switching Trial
May 19, 2017
Dr Richard J. Willke on the Value of Real-World Data for Health Plans
May 18, 2017
Dr Lou Garrison on the Discussions Surrounding Outcomes-Based Arrangements
May 17, 2017

Dr Matthew Pickering Describes Challenges of New Measure Implementation

Measure developers have a number of challenges to consider when developing a new measure and getting it implemented, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at the Pharmacy Quality Alliance (PQA).


Measure developers have a number of challenges to consider when developing a new measure and getting it implemented, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at the Pharmacy Quality Alliance (PQA).

Transcript

Does the Pharmacy Quality Alliance consider measurement fatigue when creating new quality measures? And what are the challenges of getting new measures implemented?

So measure implementation is very challenging. You can spend a lot of time and resources on developing a really good measure, but if that measure is never implemented, the impact it has is never really realized. So with measure implementation there are several challenges to consider. And as a measure developer, you have to consider those challenges along the way. Those challenges can be for one: who are the implementers. And PQA is not an implementer. We develop measures, but we don't implement. So CMS is an implementer of quality measures. So who are these implementers?

And after you identify them, for 2: how do you engage them? And when do you engage them? How do you engage these measure implementers about the value of the measures that are coming through your pipeline? Or the value of the measures that are already out there? And when you engage them, these implementers have their own set timelines for when they're going to implemen measures or when they're going to decide on what new measures to look for. So when do you enage them in these processes. Because you need to be able to do that and figure out where interests align as measure concepts are generated and as you continue to develop measures through the pipeline

And then the third thing is to consider, obviously, measurement burden and fatigue. Which is another challenge with implementation. And this is a realy concern. It's a real concern with implementers, measure developers, those being held accountable for the measures. And PQA is very well aware of this. We strive to develop measures were there are gaps, where there are gaps in care.

We also work with other measure developers, such as the National Committee for Quality Assurance to try to harmonize our measures, to try to make sure that measure specifications are the same across all of these entities so there isn't this measurement burden. And ultimately, mitigating that measurement fatigue.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!